MERK Merck Tbk


Saham MERK Merck Tbk - Berita, Prospek, dan Analisa - :
Stocks Asia - Berita saham, analisis saham, dan prospek saham
Tip: Gunakan untuk menyimpan saham-saham favorit
MERK Laporan Informasi atau Fakta Material Penyampaian AKTA  Berita Acara Rapat (BAR) dan AKTA Pernyataan Keputusan Rapat (PKR) RUPSLB PT Merck Tbk pada...
MERK Laporan Bulanan Registrasi Pemegang Efek
MERK Dow drops 100 points on losses for Chevron, Merck shares - MarketWatch
07 Jan 2020 23:58 (13 hari lalu) - The Dow Jones Industrial Average is falling Tuesday morning with shares of Chevron and Merck delivering the stiffest headwinds for the price-weighted average. Shares of Chevron CVX,-2.30% and Merck MRK,-2.01% have contributed to the blue-chip gauge's intraday decline, as the Dow DJIA,-0.38% was most recently trading 108 points, or 0.4%, lower. Chevron's shares have dropped $2.71, or 2.3%, while those of Merck have fallen $1.96, or 2.1%, combining for an approximately 32-point drag on the Dow. Also contributing significantly to the decline are Exxon Mobil XOM,-1.79%, Caterpillar CAT,-1.77%, and Walgreens Boots WBA,-1.46%. A $1 move in any one ...
MERK Merck Weighs on Dow After Clinical Trial Miss By Investing.com
07 Jan 2020 23:41 (13 hari lalu) - Investing.com - Drugmaker Merck was a drag on the Dow Jones in midday trading Tuesday as the blue-chip index struggled to follow the S&P and Nasdaq into positive territory. Merck (NYSE: MRK) shares dropped 2,2% following a disappointing clinical trial for its market-leading lung cancer treatment. The company said after the bell Monday that its drug Keytruda did not meet a statistically significant goal in treating non-small cell lung cancer in combination with chemotherapy in a phase 3 trial. Merck’s loss of a little more than $2 accounted for more than 13 points of the Dow’s 31-point loss. Keytruda has been approved to treat non-small ce ...
MERK Dow falls 37 points on losses for Merck, Chevron shares - MarketWatch
07 Jan 2020 22:58 (13 hari lalu) - Shares of Merck and Chevron are posting losses Tuesday morning, dragging the Dow Jones Industrial Average into negative territory. Shares of Merck MRK,-2.15% and Chevron CVX,-1.66% are contributing to the blue-chip gauge's intraday decline, as the Dow DJIA,-0.11% was most recently trading 37 points, or 0.1%, lower. Merck's shares have fallen $2.08, or 2.3%, while those of Chevron are down $1.95, or 1.6%, combining for an approximately 27-point drag on the Dow. Exxon Mobil XOM,-1.24%, Intel INTC,-0.84%, and Travelers TRV,-0.74% are also contributing significantly to the decline. A $1 move in any of the benchmark's 30 components equates to a ...
MERK Novartis, Merck and Allergan join those raising U.S. drug prices for 2020 By Reuters
03 Jan 2020 23:52 (17 hari lalu) - By Michael Erman NEW YORK (Reuters) - Novartis AG (S: NOVN), Merck & Co Inc (N: MRK) and Allergan Plc (N: AGN) were among companies that raised U.S. prices on more than 100 prescription medicines on Friday, bringing the tally to 445 drugs that will cost more in 2020, according to data analyzed by healthcare research firm 3 Axis Advisors. That is above the average of 404 drug price increases in the first three days of January over the past five years. Nearly all of the price increases are below 10%, with the median price increase around 5%, according to 3 Axis. Swiss drugmaker Novartis raised prices on nearly 30 drugs including psoriasis tr ...
MERK Merck Stock Leveled Out in 2019. It Could Return to its Glory Days Next Year.
30 Dec 2019 19:00 (21 hari lalu) - With the year almost over, we’re taking a look at all 30 stocks in the Dow, starting with the worst performer—Walgreens Boots Alliance—and working our way up to the highest-flying stock in the benchmark—Apple. The ranking may shift before the close of 2019 trading, but the stories behind the stocks shouldn’t. After a highflying 2018, Merck leveled out in 2019 as worries over drug pricing slowed much of the pharmaceutical sector... Subscribe or Sign In to continue reading.
MERK Caterpillar, Merck share gains contribute to Dow's nearly 100-point jump - MarketWatch
20 Dec 2019 21:45 (1 bulan 1 hari lalu) - The Dow Jones Industrial Average is climbing Friday morning with shares of Caterpillar and Merck seeing positive gains for the price-weighted average. Shares of Caterpillar CAT, +1.40% and Merck MRK, +1.11% are contributing to the index's intraday rally, as the Dow DJIA, +0.35% was most recently trading 98 points higher (0.3%). Caterpillar's shares have gained $1.95 (1.3%) while those of Merck are up $1.16, or 1.3%, combining for a roughly 21-point boost for the Dow. Also contributing significantly to the gain are Pfizer PFE, +0.80%, Walgreens Boots WBA, +1.77%, and Verizon Communications Inc. VZ, +1.24%. A $1 move in any one of the 30 ...
MERK Merck receives FDA approval for Ebola vaccine By Reuters
20 Dec 2019 15:08 (1 bulan 1 hari lalu) - (Reuters) - The U.S. Food and Drug Administration said on Thursday it approved drugmaker Merck & Co's (N: MRK) Ebola vaccine Ervebo, making it the first FDA-authorised vaccine against the deadly virus. The vaccine was used by the World Health Organization and Democratic Republic of the Congo as an investigational vaccine to help reduce Ebola virus disease (EVD) outbreaks in few West African countries from 2014 to 2016. The Ebola virus, which causes haemorrhagic fever and spreads from person to person through direct contact with body fluids, has killed more than 2,100 people in Congo since the middle of the year, making it the second-largest ...
MERK Ringkasan Risalah Rapat Umum Para Pemegang Saham Luar Biasa
Mode seleksi ketat (strict search) ON. Klik di sini untuk melihat lebih banyak artikel.
  Artikel 1 sampai 10